| Issue |
Med Sci (Paris)
Volume 40, Number 4, Avril 2024
|
|
|---|---|---|
| Page(s) | 328 - 331 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2024032 | |
| Published online | 23 April 2024 | |
Des modifications post-traductionnelles de la protéine tau soluble distinguent la maladie d’Alzheimer des autres tauopathies
Specific modifications of the soluble tau protein distinguish Alzheimer’s disease from other tauopathies
1
Université catholique de Louvain (UCLouvain), Institut de neurosciences (IONS), Bruxelles, Belgique
2
Université catholique de Louvain (UCLouvain), Institut de Duve (DDUV), Phosphorylation des protéines (PHOS), Bruxelles, Belgique
3
Université catholique de Louvain (UCLouvain), Institut de Duve (DDUV), Plateforme MASSPROT, Bruxelles, Belgique
4
Cliniques universitaires Saint-Luc, département de neurologie, Bruxelles, Belgique
5
Université catholique de Louvain (UCLouvain), département WELBIO, Institut de recherche WEL, Wavre, Belgique
6
Harvard medical school, Massachusetts general hospital, Department of radiology, Gordon center for medical imaging, Boston, États-Unis
* bernard.hanseeuw@saintluc.uclouvain.be
Cet article ne possède pas de résumé.
© 2024 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
